425: Strive CEO Discusses Semler Scientific Merger

Strive Inc.'s CEO, Matthew Cole, posted on X.com regarding the proposed business combination with Semler Scientific, Inc., emphasizing cautionary forward-looking statements.

Summary

• A communication from Strive Inc.'s CEO, Matthew Cole, on September 24, 2025, was posted on X.com concerning the proposed business combination with Semler Scientific, Inc.
• This Form 425 filing primarily serves as a cautionary statement regarding forward-looking information related to the merger, highlighting inherent risks and uncertainties.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders to approve the transaction.
• Investors and stockholders are strongly urged to read the forthcoming S-4 filing and other relevant documents for important information about both companies and the proposed transaction.
• Details regarding participants in the solicitation of proxies, including directors and executive officers of both companies, will be provided in the Information Statement/Proxy Statement/Prospectus.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily a legal disclosure about a proposed merger. While it confirms the merger is proceeding, it heavily emphasizes risks and uncertainties, balancing any positive implications with necessary cautionary statements.

Positives

• The communication confirms the ongoing progress towards the proposed business combination between Strive and Semler Scientific.
• The filing outlines the structured process for shareholder approval and provides clear guidance on where investors can find comprehensive information about the transaction.

Negatives

• The filing highlights numerous risks and uncertainties associated with the proposed transaction, including potential delays, integration difficulties, and the possibility of not realizing anticipated benefits.
• Dilution caused by Strive's issuance of additional Class A common stock in connection with the proposed transaction is explicitly mentioned as a risk.
• Potential adverse reactions from customers or changes to business and employee relationships due to the announcement or completion of the transaction are noted.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of either Strive or Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing outlines expectations for the proposed transaction, including strategic and financial benefits, the timing of closing, and the successful integration of combined businesses. However, it heavily emphasizes that these are forward-looking statements subject to significant risks and uncertainties, and actual results could differ materially from anticipated outcomes.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

This communication relates to a proposed business combination, a common strategic move in various industries for growth, market consolidation, or diversification. The explicit mention of Bitcoin treasury strategies and digital asset risks suggests Strive's involvement or planned involvement in the digital asset space, which is a growing but volatile area, potentially influencing the strategic rationale for the merger with Semler Scientific and introducing unique risk factors compared to traditional mergers.

Legal Proceedings

• The filing identifies the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company as a potential risk factor related to the merger.

Related Party Transactions

• The filing refers to Semler Scientific's transactions with related persons being set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders, indicating that such disclosures exist in other filings.

Stakeholder Impact

• Shareholders: Strive's issuance of additional Class A common stock in connection with the merger will cause dilution for existing shareholders. Semler Scientific stockholders will be required to vote on the proposed transaction.
• Customers: There is a potential for adverse reactions from customers of Strive or Semler Scientific due to the announcement or completion of the proposed transaction.
• Employees: There is a potential for changes to business or employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the forthcoming S-4 and other relevant documents when they become available.

Key Dates

Recommendation

The filing confirms the ongoing merger process between Strive and Semler Scientific but is primarily a cautionary statement regarding forward-looking information and associated risks. While the merger itself could be a catalyst, the extensive list of uncertainties, including potential delays, integration challenges, dilution, and risks related to Bitcoin treasury strategies, suggests a 'hold' position until more definitive terms, financial projections, and a clearer path to closing are available in the forthcoming S-4 filing. Investors should await the full proxy statement/prospectus for a comprehensive evaluation.

Keywords

Strive Inc., Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Corporate Governance, Investment, Bitcoin Treasury Strategy, Digital Assets